274
Participants
Start Date
May 28, 2024
Primary Completion Date
January 15, 2025
Study Completion Date
January 30, 2025
BHV-7000
BHV-7000 75 mg taken once daily for 21 days
Placebo
Matching placebo taken once daily for 21 days
RBA, Staten Island
CBH Health, Gaithersburg
CenExel iResearch, LLC, Decatur
Atlanta Center for Medical Research, Atlanta
CenExel iResearch, LLC, Savannah
Floridian Neuroscience Institute, Miami Lakes
Segal Trials - Miami Lakes Medical Research-Inpatient & Early Phase Site, Miami Lakes
Segal Trials - Larkin Behavioral Health Services-Inpatient & Early Phase Site, Hollywood
Cenexel - RCA, Hollywood
LCC Medical Research Inst, Miami
Neuroscience Research Institute, West Palm Beach
Precise Clinical Research, Flowood
NBCR, North Canton
Midwest Clinical Research Center, Dayton
Uptown Research Institute, Chicago
Pillar Clinical Research, Chicago
Arch Clinical Trials, St Louis
WIRG, Little Rock
Pillar Clinical Research, LLC, Bentonville
WRN, Rogers
Pillar Clinical Research, LLC, Richardson
InSite Clinical Research, LLC, DeSoto
Community Clinical Research, Inc., Austin
ProScience Research Group, Culver City
Cenexel CNS, Torrance
CIT LA, Bellflower
Synergy San Diego, Lemon Grove
CIT IE, Riverside
Advanced Research Center, Inc., Anaheim
Cenexel CNS, Garden Grove
NRC Research Institute, Orange
Hassman Research Institute, Marlton
Lead Sponsor
Biohaven Therapeutics Ltd.
INDUSTRY